By Professor Andrew Stewart Day

Journal articles

Day AS, 2019, 'Switching off Inflammation with Diet: A Review of Exclusive Enteral Nutrition in Children with Crohn’s Disease', EMJ Gastroenterology, pp. 86 - 94, http://dx.doi.org/10.33590/emjgastroenterol/10314458

Rahmani J; Kord-Varkaneh H; Ryan PM; Rashvand S; Clark C; Day AS; Hekmatdoost A, 2019, 'Dietary total antioxidant capacity and risk of ulcerative colitis: A case-control study', Journal of Digestive Diseases, 20, pp. 636 - 641, http://dx.doi.org/10.1111/1751-2980.12823

Rahmani J; Varkaneh HK; Ryan PM; Zarezadeh M; Rashvand S; Clark C; Day AS; Hekmatdoost A, 2019, 'Healthy Eating Index-2015 as a predictor of ulcerative colitis risk in a case–control cohort', Journal of Digestive Diseases, 20, pp. 649 - 655, http://dx.doi.org/10.1111/1751-2980.12826

Isoldi S; Belsha D; Yeop I; Uc A; Zevit N; Mamula P; Loizides AM; Tabbers M; Cameron D; Day AS; Abu-El-Haija M; Chongsrisawat V; Briars G; Lindley KJ; Koeglmeier J; Shah N; Harper J; Syed SB; Thomson M, 2019, 'Diagnosis and management of children with Blue Rubber Bleb Nevus Syndrome: A multi-center case series', Digestive and Liver Disease, 51, pp. 1537 - 1546, http://dx.doi.org/10.1016/j.dld.2019.04.020

Shaoul R; Day AS, 2019, 'Nutritional regulators of intestinal inflammation', Current Opinion in Gastroenterology, 35, pp. 486 - 490, http://dx.doi.org/10.1097/MOG.0000000000000585

Appleton L; Day AS, 2019, 'Re: A meta-analysis of the clinical use of curcumin for irritable bowel syndrome', Journal of Clinical Medicine, 8, http://dx.doi.org/10.3390/jcm8111885

Wall CL; Day AS, 2019, 'Editorial: the reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food reintroduction', Alimentary Pharmacology and Therapeutics, 50, pp. 824 - 825, http://dx.doi.org/10.1111/apt.15475

Thurgate LE; Lemberg DA; Day AS; Leach ST, 2019, 'An overview of inflammatory bowel disease unclassified in children', Inflammatory Intestinal Diseases, 4, pp. 97 - 103, http://dx.doi.org/10.1159/000501519

Vernon-Roberts A; Lopez RN; Frampton C; Gearry RB; Lemberg DA; Day AS, 2019, 'A Symptom Self-report Tool for Children with Inflammatory Bowel Disease (IBDnow)', Journal of Pediatric Gastroenterology and Nutrition, 69, pp. E7 - E12, http://dx.doi.org/10.1097/MPG.0000000000002329

Day AS; Ho SSC; Leach ST, 2019, 'Letter to the Editor Re: Serum Calprotectin in Adolescents with Inflammatory Bowel Disease', Journal of Pediatric Gastroenterology and Nutrition, 68, pp. e109, http://dx.doi.org/10.1097/MPG.0000000000002345

Wall CL; McCombie AM; Gearry RB; Day AS, 2019, 'Newly diagnosed Crohn's disease treated with standard care or enteral nutrition: Psychological outcomes over 6 months', Inflammatory Intestinal Diseases, 4, pp. 7 - 13, http://dx.doi.org/10.1159/000497323

Adamji M; Day AS, 2019, 'An overview of the role of exclusive enteral nutrition for complicated Crohn's disease', INTESTINAL RESEARCH, 17, pp. 171 - 176, http://dx.doi.org/10.5217/ir.2018.00079

Ho SSC; Day AS, 2019, 'Exclusive enteral nutrition in children with inflammatory bowel disease: Physician perspectives and practice', JGH Open, 3, pp. 148 - 153, http://dx.doi.org/10.1002/jgh3.12121

Khan A; Berahmana AB; Day AS; Barclay ML; Schultz M, 2019, 'New Zealand society of gastroenterology guidelines on therapeutic drug monitoring in inflammatory bowel disease', New Zealand Medical Journal, 132, pp. 46 - 62

Rigterink T; Appleton L; Day AS, 2019, 'Vitamin D therapy in children with inflammatory bowel disease: A systematic review', World Journal of Clinical Pediatrics, 8, pp. 1 - 14, http://dx.doi.org/10.5409/wjcp.v8.i1.1

Rahmani J; Kord-Varkaneh H; Hekmatdoost A; Thompson J; Clark C; Salehisahlabadi A; Day AS; Jacobson K, 2019, 'Body mass index and risk of inflammatory bowel disease: A systematic review and dose-response meta-analysis of cohort studies of over a million participants', Obesity Reviews, 20, pp. 1312 - 1320, http://dx.doi.org/10.1111/obr.12875

Lemberg DA; Day AS, 2019, 'Editorial: predicting response to treatment in children with Crohn's disease', Alimentary Pharmacology and Therapeutics, 49, pp. 230 - 231, http://dx.doi.org/10.1111/apt.15069

Cohen IS; Day AS; Shaoul R, 2019, 'Gluten in celiac disease more or less?', Rambam Maimonides Medical Journal, 10, http://dx.doi.org/10.5041/RMMJ.10360

Day AS, 2019, 'Inflammatory bowel disease in children', Translational Pediatrics, 8, pp. 1 - 3, http://dx.doi.org/10.21037/tp.2019.01.05

O’brien L; Brown S; Gearry RB; Day AS, 2019, 'Letter: low FODMAP diet—directions for future research', Alimentary Pharmacology and Therapeutics, 49, pp. 1107 - 1108, http://dx.doi.org/10.1111/apt.15175

Martin NG; Rigterink T; Adamji M; Wall CL; Day AS, 2019, 'Single high-dose oral vitamin D3 treatment in New Zealand children with inflammatory bowel disease', Translational Pediatrics, 8, pp. 35 - 41, http://dx.doi.org/10.21037/tp.2018.11.01

Cohen IS; Day AS; Shaoul R, 2019, 'To be oats or not to be? An update on the ongoing debate on oats for patients with celiac disease', Frontiers in Pediatrics, 7, http://dx.doi.org/10.3389/fped.2019.00384

Karim S; Porter JA; McCombie A; Gearry RB; Day AS, 2019, 'Transition clinics: An observational study of themes important to young people with inflammatory bowel disease', Translational Pediatrics, 8, pp. 83 - 89, http://dx.doi.org/10.21037/tp.2019.01.04

Volkers A; Appleton L; Leach ST; Lemberg D; Day AS, 2019, 'Sa1761 – Chitinase 3-Like-1 Protein: A Novel Biomarker of Disease Activity and Risk of Relapse in Children with Inflammatory Bowel Disease', Gastroenterology, 156, pp. S - 391, http://dx.doi.org/10.1016/s0016-5085(19)37828-x

Day AS; Moeeni V; Walls T, 2018, 'A Retrospective Comparison between the PNST and other Paediatric Nutritional Screening Tools', International Journal of Child Health and Nutrition, 7, pp. 97 - 101, http://dx.doi.org/10.6000/1929-4247.2018.07.03.1

Day AS, 2018, 'Gastric emptying in children with type 1 diabetes mellitus: A pilot study', Journal of Paediatrics and Child Health, pp. 1 - 5, http://dx.doi.org/10.1111/jpc.14215

Lawley M; Wu JW; Navas-López VM; Huynh HQ; Carroll MW; Chen M; Medvedev P; Day AS; Hussey S; Sigall-Boneh R; Levine A; Wine E, 2018, 'Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease', Journal of pediatric gastroenterology and nutrition, 67, pp. e22 - e29, http://dx.doi.org/10.1097/MPG.0000000000001946

Wall CL; Gearry RB; Day AS, 2018, 'Erratum: Treatment of active Crohn's disease with exclusive and partial enteral nutrition: A pilot study in adults (Inflammatory Intestinal Diseases (2018) 2: 4 (219-227) DOI: 10.1159/000489630)', Inflammatory Intestinal Diseases, 2, pp. 236, http://dx.doi.org/10.1159/000491914

Wall CL; Gearry RB; Day AS, 2018, 'Treatment of Active Crohn's Disease with Exclusive and Partial Enteral Nutrition: A Pilot Study in Adults', Inflammatory Intestinal Diseases, 2, pp. 219 - 227, http://dx.doi.org/10.1159/000489630

Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS, 2018, 'Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results from the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. e122 - e126, http://dx.doi.org/10.1097/MPG.0000000000001806

Shaoul R; Brown S; Day AS, 2018, 'Reasoning beyond the Potential Use of Exclusive Enteral Nutrition and Other Specified Diets in Children with Ulcerative Colitis', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. 378 - 382, http://dx.doi.org/10.1097/MPG.0000000000001785

Lopez RN; Appleton L; Gearry RB; Day AS, 2018, 'Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. e45 - e50, http://dx.doi.org/10.1097/MPG.0000000000001688

Day AS; Gulati AS; Patel N; Boyle B; Park KT; Saeed SA, 2018, 'The Role of Combination Therapy in Pediatric Inflammatory Bowel Disease: A Clinical Report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. 361 - 368, http://dx.doi.org/10.1097/MPG.0000000000001850

Galgut BJ; Lemberg DA; Day AS; Leach ST, 2018, 'The value of fecal markers in predicting relapse in inflammatory bowel diseases', Frontiers in Pediatrics, 5, pp. 292, http://dx.doi.org/10.3389/fped.2017.00292

Garg M; Leach ST; Pang T; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2018, 'Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old', Journal of Cystic Fibrosis, 17, pp. 109 - 113, http://dx.doi.org/10.1016/j.jcf.2017.07.011

Garg M; Leach ST; Day AS; Ooi CY, 2018, 'Fecal calprotectin concentrations in young children with cystic fibrosis: Authors response', Journal of Cystic Fibrosis, 17, pp. e10 - e11, http://dx.doi.org/10.1016/j.jcf.2017.10.012

Day AS, 2018, 'Re: American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease', Translational Pediatrics, 7, pp. 11 - 13, http://dx.doi.org/10.21037/tp.2017.12.03

Day AS, 2018, 'The impact of exclusive enteral nutrition on the intestinal microbiota in inflammatory bowel disease', AIMS Microbiology, 4, pp. 584 - 593, http://dx.doi.org/10.3934/MICROBIOL.2018.4.584

Nazari A; Khorramdelazad H; Hassanshahi G; Day AS; Sardoo AM; Fard ET; Abedinzadeh M; Nadimi AE, 2017, 'S100A12 in renal and cardiovascular diseases', Life Sciences, 191, pp. 253 - 258, http://dx.doi.org/10.1016/j.lfs.2017.10.036

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Wall CL; Gearry RB; Day AS, 2017, 'New Zealand gastroenterologists’ perceptions, knowledge and experience of exclusive enteral nutrition to treat crohn’s disease', New Zealand Medical Journal, 130, pp. 77 - 79

Splawski JB; Pffefferkorn MD; Schaefer ME; Day AS; Soldes OS; Ponsky TA; Stein P; Kaplan JL; Saeed SA, 2017, 'NASPGHAN Clinical Report on Postoperative Recurrence in Pediatric Crohn Disease', Journal of Pediatric Gastroenterology and Nutrition, 65, pp. 475 - 486, http://dx.doi.org/10.1097/MPG.0000000000001606

Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; Van Rheenen PF; Van De Vijver E; Wilson DC; Reitsma JB; Berger MY, 2017, 'Use of laboratory markers in addition to symptoms for diagnosis of inflammatory bowel disease in children: A meta-analysis of individual patient data', JAMA Pediatrics, 171, pp. 984 - 991, http://dx.doi.org/10.1001/jamapediatrics.2017.1736

Day AS; Brown SC, 2017, 'The adjunctive role of nutritional therapy in the management of phlegmon in two children with Crohn's disease', Frontiers in Pediatrics, 5, http://dx.doi.org/10.3389/fped.2017.00199

Day AS; Leach ST; Lemberg DA, 2017, 'An update on diagnostic and prognostic biomarkers in inflammatory bowel disease', Expert Review of Molecular Diagnostics, 17, pp. 835 - 843, http://dx.doi.org/10.1080/14737159.2017.1364160

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Pang T; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. 631 - 636, http://dx.doi.org/10.1016/j.jcf.2017.03.010

McCombie A; Gearry RB; Lopez RN; Lönnfors S; Day AS, 2017, 'Enhancements in Confidence, Acceptance, and Friendship at a Summer Camp for Children with Inflammatory Bowel Disease', Journal of Pediatric Gastroenterology and Nutrition, 65, pp. 311 - 313, http://dx.doi.org/10.1097/MPG.0000000000001526

Flores SE; Aitchison A; Day AS; Keenan JI, 2017, 'Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells', PLoS ONE, 12, http://dx.doi.org/10.1371/journal.pone.0184026

Day AS; Mylvaganam G; Shalloo N; Clarkson C; Leach ST; Lemberg DA, 2017, 'Assessment of disease-specific knowledge in Australian children with inflammatory bowel disease and their parents', Journal of Paediatrics and Child Health, 53, pp. 778 - 781, http://dx.doi.org/10.1111/jpc.13544

Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS, 2017, 'Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study', Inflammatory Bowel Diseases, 23, pp. 1418 - 1424, http://dx.doi.org/10.1097/MIB.0000000000001138

Back to profile page